Drug

Polyethylene Glycol 400 And Propylene Glycol

77 flagged reaction(s) · 5,134 total co-reports · max PRR 97.4

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Eye Discharge	177	97.4	102.1	signal
2	Eye Irritation	956	96.4	128.4	signal
3	Eye Pruritus	317	53.6	58.4	signal
4	Ocular Hyperaemia	406	48.4	54.1	signal
5	Eye Pain	450	45.4	51.3	signal
6	Dry Eye	390	44.8	49.8	signal
7	Product Odour Abnormal	71	38.0	38.7	signal
8	Lacrimation Increased	190	35.3	37.1	signal
9	Ocular Discomfort	63	32.2	32.7	signal
10	Vision Blurred	630	25.6	30.5	signal
11	Eye Infection	38	18.8	19.0	signal
12	Eyelid Oedema	36	17.0	17.2	signal
13	Eye Inflammation	27	15.8	16.0	signal
14	Eye Swelling	104	15.6	16.0	signal
15	Poor Quality Product Administered	24	13.0	13.1	signal
16	Intraocular Pressure Increased	30	12.9	13.0	signal
17	Photophobia	42	12.4	12.6	signal
18	Expired Product Administered	71	11.8	12.0	signal
19	Product Quality Issue	251	10.3	11.0	signal
20	Product Packaging Issue	17	10.1	10.2	signal
21	Madarosis	21	9.9	10.0	signal
22	Vitreous Floaters	14	7.9	8.0	signal
23	Eye Haemorrhage	18	7.4	7.5	signal
24	Glaucoma	25	7.2	7.2	signal
25	Seasonal Allergy	18	7.0	7.1	signal
26	Conjunctivitis	23	6.9	7.0	signal
27	Visual Acuity Reduced	41	6.8	6.8	signal
28	Eye Disorder	38	6.4	6.5	signal
29	Cyst	12	5.3	5.3	signal
30	Cataract	57	5.3	5.4	signal
31	Secretion Discharge	11	4.9	4.9	signal
32	Eyelid Ptosis	9	4.9	4.9	signal
33	Retinal Detachment	8	4.8	4.8	signal
34	Hypoaesthesia Oral	13	4.8	4.8	signal
35	Visual Impairment	104	4.7	4.8	signal
36	Dry Throat	8	4.4	4.4	signal
37	Flank Pain	7	4.1	4.1	signal
38	Taste Disorder	14	3.9	3.9	signal
39	Immune System Disorder	9	3.8	3.8	signal
40	Blindness Unilateral	9	3.5	3.5	signal
41	Wrong Technique In Drug Usage Process	23	3.4	3.5	signal
42	Mydriasis	8	3.4	3.5	signal
43	Diplopia	16	3.4	3.4	signal
44	Macular Degeneration	6	2.8	2.8	signal
45	Bladder Disorder	5	2.8	2.8	signal
46	Paraesthesia Oral	7	2.7	2.7	signal
47	Photosensitivity Reaction	8	2.7	2.7	signal
48	Product Packaging Quantity Issue	5	2.5	2.5	no signal
49	Sinus Disorder	9	2.5	2.5	signal
50	Product Administration Error	9	2.5	2.5	signal
51	Sinus Congestion	6	2.4	2.5	no signal
52	Pelvic Pain	8	2.4	2.4	signal
53	Brain Neoplasm	4	2.4	2.4	no signal
54	Nerve Compression	4	2.4	2.4	no signal
55	Heart Rate Irregular	9	2.2	2.2	signal
56	Inappropriate Schedule Of Drug Administration	28	2.1	2.2	signal
57	Sneezing	8	2.0	2.0	no signal
58	Local Swelling	6	1.9	1.9	no signal
59	Hypoacusis	14	1.8	1.8	no signal
60	Dysgeusia	24	1.8	1.8	no signal
61	Incorrect Route Of Drug Administration	11	1.7	1.7	no signal
62	Incorrect Product Storage	4	1.7	1.7	no signal
63	Product Taste Abnormal	4	1.6	1.6	no signal
64	Drug Administration Error	7	1.2	1.2	no signal
65	Wrong Technique In Product Usage Process	41	1.1	1.1	no signal
66	Skin Burning Sensation	14	1.1	1.1	no signal
67	Skin Irritation	9	1.1	1.1	no signal
68	Incorrect Dose Administered	44	1.1	1.1	no signal
69	Drug Dispensing Error	3	1.1	1.1	no signal
70	Application Site Pain	4	1.0	1.0	no signal
71	Device Use Issue	3	1.0	1.0	no signal
72	Accidental Exposure To Product	16	0.9	0.9	no signal
73	Injection Site Urticaria	3	0.7	0.7	no signal
74	Breast Cancer Female	3	0.6	0.6	no signal
75	Dermatitis Atopic	5	0.6	0.6	no signal
76	Product Adhesion Issue	3	0.5	0.5	no signal
77	Device Difficult To Use	4	0.3	0.3	no signal